FDA Debuts List For Rapidly Announcing Noncompliant Ingredients In Supplements
Executive Summary
FDA announces addition of Dietary Supplement Ingredient Advisory List page to its website to identify ingredients it has preliminary determined should be used in dietary supplements. It also publishes warning letters submitted recently to firms marketing supplements containing two ingredients agency has concluded should not be used: eight were warned about using an ingredient identified as "DMHA" and three about using phenibut.
New to HBW Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
